Iconovo AB

Iconovo AB's capital structure is characterized by a low debt-to-equity ratio of 0.03, indicating a conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.01, suggesting limited short-term liquidity cushion. The price-to-book ratio of 0.96 implies that the market values the company slightly below its book value, while the price-to-tangible-book ratio is identical, indicating no significant intangible asset premium.

Profitability metrics reveal a challenging operating environment for Iconovo AB. The company reported a net loss of -43,363,860 SEK and an operating loss of -43,112,760 SEK, resulting in a negative return on equity of -36.77% and a return on assets of -33.08%. These figures fall significantly below the industry's median profitability metrics, highlighting a need for operational improvements or cost restructuring.

Iconovo AB's revenue is concentrated within its core business of medical equipment and supplies, with no disclosed geographic diversification in the provided data. The company's exposure to a single business line increases its vulnerability to sector-specific downturns or supply chain disruptions. No segment-specific revenue breakdown is available in the input data.

The company's growth trajectory is currently negative, with a net loss and declining cash flows. The operating cash flow of -31,870,880 SEK and free cash flow of -47,751,660 SEK indicate a cash outflow, which could constrain future growth initiatives. The capital expenditure of -14,089,110 SEK suggests ongoing investment in infrastructure, but the negative cash flow may limit the sustainability of such investments.

Risk factors for Iconovo AB include medium liquidity risk, as the company has negative net cash after subtracting total debt. The dilution risk is assessed as low, with no near-term pressure from share issuance. However, the company's negative operating and net income may necessitate future financing, which could introduce dilution risk if not managed carefully.

Recent events and filings have not been disclosed in the input data, so no specific recent developments can be cited. The company's financial performance and risk profile suggest a need for close monitoring of its liquidity and profitability trends.